Machina Capital S.A.S. Horizon Therapeutics Public LTD CO Transaction History

Machina Capital S.A.S.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$98.98 - $115.74 $513,409 - $600,343	-5,187 Reduced 57.52%	3,831 $443,000
Q2 2023 Aug 08, 2023	SELL	$96.34 - $112.38 $23,314 - $27,195	-242 Reduced 2.61%	9,018 $927,000
Q1 2023 Apr 24, 2023	BUY	$107.32 - $113.5 $993,783 - $1.05 Million	9,260 New	9,260 $1.01 Million
Q2 2022 Aug 08, 2022	BUY	$79.4 - $116.36 $325,540 - $477,076	4,100 New	4,100 $327,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

Stay updated on Machina Capital S.A.S. with notifications on news.